FDA Gives Thumbs Down to Nuvigil for Jet Lag
By Catherine Shaffer
Tuesday, December 28, 2010
Cephalon Inc. will not pursue approval of its sleep disorder drug Nuvigil (armodafinil) for jet lag following a second complete response letter from the FDA.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.